(0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION (Q4129234): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in es, and other parts: Adding Spanish translations)
(‎Changed label, description and/or aliases in en, and other parts: Adding English translations)
label / enlabel / en
 
(0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION
Property / summary
 
(0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION (English)
Property / summary: (0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION (English) / rank
 
Normal rank
Property / summary: (0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION (English) / qualifier
 
point in time: 31 January 2022
Timestamp+2022-01-31T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 09:01, 31 January 2022

Project Q4129234 in Italy
Language Label Description Also known as
English
(0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION
Project Q4129234 in Italy

    Statements

    0 references
    5,000.0 Euro
    0 references
    10,000.0 Euro
    0 references
    50.0 percent
    0 references
    LOGIDEX SRL
    0 references
    0 references
    0 references
    (0350000119) COVID:REALIZZAZIONE DI UN COLLUTORIO A BASE DI RESVERATROLO COMPLESSATO CON CICLODESTRINE PER PREVENIRE IL DIFFONDERSI DEL SARS-COV-2 MEDIANTE AEROSOL SALIVARE: SPERIMENTAZIONE PRECLINICA (Italian)
    0 references
    (0350000119) COVID:REALIZZAZIONE DE UN ENJUAGUE BUCAL A BASE DE RESVERATROL COMPLEJO CON CICLODEXTRINA PARA PREVENIR LA PROPAGACIÓN DEL SARS-COV-2 POR AEROSOLES SALIVALES: EXPERIMENTACIÓN PRECLÍNICA (Spanish)
    30 January 2022
    0 references
    (0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION (English)
    31 January 2022
    0 references
    TORINO
    0 references

    Identifiers